We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




LGC Standards Opens First Chinese Office

By LabMedica International staff writers
Posted on 29 Apr 2009
LGC Standards (Teddington, UK) has opened its first office in Beijing, China, signaling a milestone in the company's international development. More...
The new office will enable the company to bring its range of laboratory quality products and services to the Chinese market.

LGC Standards provides a range of products and services for measurement and laboratory control through the quick and efficient supply of reference materials and proficiency testing schemes. The company will be able to support Chinese laboratories directly by offering logistical and technical advice in their local language.

Dr Matthias Brommer, director, LGC Standards said: "The opening of our first Chinese office clearly demonstrates that LGC Standards is committed to providing global quality management solutions for laboratories worldwide. Our Chinese team will focus on supplying laboratories in the pharmaceutical, environmental, food, industrial, and forensic sectors with reference materials and proficiency testing schemes to support laboratory quality."

In welcoming LGC China to the Group, David Richardson, Chief Executive of LGC, commented, "Our new office provides an excellent opportunity for LGC to serve the Chinese scientific community and gives us a base from which to partner with local businesses on future projects. Our investment strengthens LGC's position as an international leader in reference materials.”

The company supplies over 20,000 reference materials, pharmaceutic impurity reference standards, proficiency testing and training in analytical quality. LGC Standards has offices in France, Germany, Italy, Poland, Spain, Sweden, China, and the UK, a joint venture presence in India, and representatives in Bulgaria, Czech Republic, Finland, Hungary, Ireland, Romania, Turkey, and the United States.

LGC is an international science-based company and market leader in diagnostic, analytical, and forensic services and reference standards. A progressive and innovative enterprise, LGC operates in socially responsible fields underpinning the safety, health, and security of the public and the regulation of industry, for U.K. government departments, and blue chip clients.

Related Links:

LGC Standards




Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Online QC Software
Acusera 24•7
Benchtop Thermomixer
Biometra TS1 ThermoShaker
Automatic CLIA Analyzer
Shine i6000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Microbiology

view channel
Image: The study compares rapid molecular CPE diagnostics, which can return results in about one hour, with culture-based screening, which typically takes about 48 hours (Image credit: Adobe Stock)

Rapid Molecular Screening Aims to Accelerate Hospital Infection Control for CPE

Drug-resistant infections remain a critical patient-safety threat in hospitals, with carbapenemase-producing Enterobacterales (CPE) among the most urgent concerns. In England, reports of acquired carbapenemase... Read more

Pathology

view channel
Image: The VENTANA PTEN (SP218) RxDx Assay is a qualitative IHC assay for assessing PTEN protein in prostate adenocarcinoma, with staining performed using the OptiView DAB IHC Detection Kit on a BenchMark ULTRA instrument (Photo courtesy of Roche)

New Companion Diagnostic Expands Precision Medicine in Prostate Cancer

Prostate cancer is a leading cancer diagnosis in men and becomes particularly aggressive when it presents as metastatic, hormone-sensitive disease. Tumors with loss of phosphatase and tensin homolog (PTEN)... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.